Applied Aerospace & Defense Debuts on NYSE at $3.5 Billion Valuation as Shares Rise on First Day of Trading
Applied Aerospace & Defense made its stock market debut on the New York Stock Exchange (NYSE) this week, with shares rising on the first day of trading and valuing the company at $3.5 billion. The IPO (initial public offering — the first public sale of shares to investors) represents one of the more significant aerospace and defence sector listings in recent months. Commentary following the debut noted that the company's enterprise multiple (a valuation metric comparing enterprise value to earnings before interest, taxes, depreciation and amortisation — EBITDA) was considered elevated, with market observers noting the pricing was on the higher end for the sector. No specific underwriters or legal advisers were named in the sources. The listing lands against a backdrop of escalating geopolitical tension — including the ongoing Iran conflict affecting global oil markets and driving heightened defence investment sentiment — while European equity markets braced for a lower open on Thursday as US-Iran tensions escalated further. The debut follows the wave of defence and aerospace sector momentum seen across capital markets in recent months, as investors have pivoted toward hard-asset, government-contract-backed businesses in an uncertain macro environment. No UK or European exchange listing was involved, though the deal is indicative of the broader aerospace IPO pipeline that advisers on both sides of the Atlantic are monitoring.
Why this matters
A $3.5 billion aerospace and defence IPO on the NYSE illustrates the sustained investor appetite for defence-sector equity issuance driven by geopolitical risk, even as broader markets face volatility from the Iran conflict. The elevated enterprise multiple flagged by commentators raises questions about long-term valuation sustainability and the risk of post-IPO share price pressure — a factor that affects underwriter liability and lock-up provisions in the listing documentation. For UK-focused practitioners, the deal is relevant as a comparable for any planned London-market aerospace or defence listings, and as a signal of where capital markets demand is concentrated. The absence of named advisers limits firm-specific analysis, but the deal activates equity capital markets, securities, and corporate governance work.
On the Ground
A trainee on an IPO matter would assist with proofreading and verifying facts in the prospectus, coordinating comfort letter requests from auditors, and preparing PDMR (persons discharging managerial responsibilities) notification letters ahead of listing. They would also help manage the verification note process, cross-checking each factual statement in the prospectus against underlying source documents.
Interview prep
Soundbite
Defence sector IPOs command premium multiples right now — geopolitical risk is a capital markets tailwind.
Question you might get
“What legal risks does an elevated enterprise multiple at IPO create for underwriters and the issuer's directors, and how might those risks be managed in the listing documentation?”
Full answer
Applied Aerospace & Defense listed on the NYSE this week at a $3.5 billion valuation, with shares rising on debut despite commentary that its enterprise multiple — the ratio of enterprise value to EBITDA — was elevated. The deal reflects a broader trend of defence and aerospace companies accessing public markets as geopolitical tensions, including the Iran conflict, sustain government procurement spending and investor appetite. The high multiple is a double-edged sword: it validates sector momentum but increases the risk of post-IPO volatility if earnings disappoint. For capital markets practitioners, defence-sector listings are generating significant underwriting, prospectus, and governance advisory work on both sides of the Atlantic.
Sources
My notes
saved